Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AUNA Stock Forecast 2026-2027
$5.09
Current Price
$376.73M
Market Cap
Buy 5
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to AUNA Price Targets
+76.8%
To High Target of $9.00
+35.6%
To Median Target of $6.90
+17.9%
To Low Target of $6.00
AUNA Price Momentum
+5.4%
1 Week Change
+2.6%
1 Month Change
-26.1%
1 Year Change
+3.5%
Year-to-Date Change
-32.8%
From 52W High of $7.57
+14.1%
From 52W Low of $4.46
📊 TOP ANALYST CALLS
Did AUNA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Auna is one of their latest high-conviction picks.
Latest AUNA Stock Price Targets & Analyst Predictions
Based on our analysis of 5 Wall Street analysts, AUNA has a bullish consensus with a median price target of $6.90 (ranging from $6.00 to $9.00). The overall analyst rating is Strong Buy (8.6/10). Currently trading at $5.09, the median forecast implies a 35.6% upside. This outlook is supported by 5 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Antonio Pedro Cardoso at Jefferies, projecting a 76.8% upside. Conversely, the most conservative target is provided by Joseph Giordano at JP Morgan, suggesting a 17.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AUNA Analyst Ratings
5
Buy
2
Hold
0
Sell
AUNA Price Target Range
Low
$6.00
Average
$6.90
High
$9.00
Current: $5.09
Latest AUNA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AUNA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 16, 2026 | Jefferies | Antonio Pedro Cardoso | Buy | Initiates | $9.00 |
| Nov 18, 2025 | JP Morgan | Joseph Giordano | Neutral | Downgrade | $6.00 |
| Feb 11, 2025 | JP Morgan | Joseph Giordano | Overweight | Maintains | $13.50 |
| Sep 20, 2024 | JP Morgan | Joseph Giordano | Overweight | Maintains | $13.00 |
| Aug 20, 2024 | JP Morgan | Joseph Giordano | Overweight | Maintains | $14.00 |
| Apr 23, 2024 | HSBC | Raj Sinha | Buy | Initiates | $12.60 |
| Apr 16, 2024 | Morgan Stanley | Mauricio Cepeda | Overweight | Initiates | $14.00 |
| Apr 16, 2024 | JP Morgan | Joseph Giordano | Overweight | Initiates | $16.00 |
| Apr 16, 2024 | Citigroup | Leandro Bastos | Buy | Initiates | $14.00 |
Auna S.A. (AUNA) Competitors
The following stocks are similar to Auna based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Auna S.A. (AUNA) Financial Data
Auna S.A. has a market capitalization of $376.73M with a P/E ratio of 5.5x. The company generates $1.28B in trailing twelve-month revenue with a 2.2% profit margin.
Revenue growth is +6.6% quarter-over-quarter, while maintaining an operating margin of +12.8% and return on equity of +6.5%.
Valuation Metrics
Market Cap
$376.73M
Enterprise Value
$1.20B
P/E Ratio
5.5x
PEG Ratio
0.0x
Price/Sales
0.1x
Growth & Margins
Revenue Growth (YoY)
+6.6%
Gross Margin
+39.7%
Operating Margin
+12.8%
Net Margin
+2.2%
EPS Growth
+245.8%
Financial Health
Cash/Price Ratio
+96.7%
Current Ratio
1.1x
Debt/Equity
223.1x
ROE
+6.5%
ROA
+5.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Auna S.A. (AUNA) Business Model
About Auna S.A.
What They Do
Provides healthcare services in Latin America.
Business Model
Auna S.A. generates revenue by operating a network of hospitals, clinics, and outpatient centers that offer a variety of medical services, from general care to specialized treatments. The company focuses on delivering high-quality healthcare solutions while leveraging advanced medical technology to enhance patient care.
Additional Information
With a commitment to innovation and sustainability, Auna S.A. aims to improve healthcare accessibility and quality in Latin America. Its strategic focus on meeting the evolving healthcare needs of the population positions it as a key player in the region's healthcare infrastructure.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
14,605
CEO
Mr. Jesús Antonio Zamora Leon
Country
Luxembourg
IPO Year
2024
Website
www.aunainvestors.comAuna S.A. (AUNA) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Auna S.A. (AUNA) Tops Q4 Earnings and Revenue Estimates
Auna S.A. (AUNA) delivered earnings and revenue surprises of +324.00% and +1.92%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Mar 10, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Auna S.A. reported its Q4 2025 earnings, detailing its financial performance and key metrics. Further specifics on revenue and profit figures were discussed in the earnings call.
Why It Matters
Auna S.A.'s Q4 2025 earnings call provides insights into financial performance and strategic direction, impacting stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Auna S.A. reported quarterly earnings of $0.53 per share, exceeding the Zacks Consensus Estimate of $0.13, and up from $0.12 per share a year earlier.
Why It Matters
Auna S.A.'s significant earnings beat signals strong performance and growth potential, likely boosting investor confidence and driving stock prices higher.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
AUNA's Mexico operations showed Q4 stabilization with a 35% sequential increase in oncology revenues, supported by new insurer and ISSSTELEON deals for 2026 growth.
Why It Matters
AUNA's Q4 stabilization and 35% oncology revenue increase signal strong operational improvement and growth potential, boosting investor confidence in future performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Auna S.A. (AUNA) and Brookdale Senior Living (BKD) are being compared to their sector's performance for the year to date. Further details on specific performance metrics were not provided.
Why It Matters
Performance comparison indicates how Auna S.A. and Brookdale Senior Living are faring against industry benchmarks, influencing investor sentiment and potential investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Auna (NYSE: AUNA), a healthcare platform in Latin America, announced its 4Q25 and FY25 financial results, reported in Peruvian Soles and compliant with IFRS.
Why It Matters
Auna's financial results impact its valuation and growth prospects, influencing investor sentiment and stock performance in the healthcare sector in Latin America.
Source: Business Wire
Market Sentiment:
Neutral
Best Value Stocks to Buy for March 11th
3 days ago
Quick Summary
AUNA, ARW, and DECK received a Zacks Rank #1 (Strong Buy) as of March 11, 2026, indicating strong investment potential in the value stocks category.
Why It Matters
AUNA, ARW, and DECK being ranked as Strong Buy indicates strong potential for growth, attracting investors looking for undervalued stocks with upward momentum.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About AUNA Stock
What is Auna S.A.'s (AUNA) stock forecast for 2026?
Based on our analysis of 5 Wall Street analysts, Auna S.A. (AUNA) has a median price target of $6.90. The highest price target is $9.00 and the lowest is $6.00.
Is AUNA stock a good investment in 2026?
According to current analyst ratings, AUNA has 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.09. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AUNA stock?
Wall Street analysts predict AUNA stock could reach $6.90 in the next 12 months. This represents a 35.6% increase from the current price of $5.09. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Auna S.A.'s business model?
Auna S.A. generates revenue by operating a network of hospitals, clinics, and outpatient centers that offer a variety of medical services, from general care to specialized treatments. The company focuses on delivering high-quality healthcare solutions while leveraging advanced medical technology to enhance patient care.
What is the highest forecasted price for AUNA Auna S.A.?
The highest price target for AUNA is $9.00 from Antonio Pedro Cardoso at Jefferies, which represents a 76.8% increase from the current price of $5.09.
What is the lowest forecasted price for AUNA Auna S.A.?
The lowest price target for AUNA is $6.00 from Joseph Giordano at JP Morgan, which represents a 17.9% increase from the current price of $5.09.
What is the overall AUNA consensus from analysts for Auna S.A.?
The overall analyst consensus for AUNA is bullish. Out of 5 Wall Street analysts, 5 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $6.90.
How accurate are AUNA stock price projections?
Stock price projections, including those for Auna S.A., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: March 15, 2026 2:10 AM UTC